• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Financial Strategies Acquisition Corp. (Amendment)

    2/14/23 6:59:52 AM ET
    $FXCO
    Blank Checks
    Finance
    Get the next $FXCO alert in real time by email
    SC 13G/A 1 formsc13ga.htm FORM SC 13G/A Saba Capital Management, L.P.: Form SC 13G/A - Filed by newsfilecorp.com

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    SCHEDULE 13G/A

    Under the Securities Exchange Act of 1934

    (Amendment No. 1)*

    Financial Strategies Acquisition Corp

    (Name of Issuer)

    Common Stock, $0.0001 par value

    (Title of Class of Securities)

     

    31772T206

    (CUSIP Number)

     

    December 31, 2022

    (Date of Event which Requires Filing of this Statement)

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     [_]  Rule 13d-1(b)

     [X]  Rule 13d-1(c)

     [_]  Rule 13d-1(d)

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


    SCHEDULE 13G/A

    CUSIP No.           31772T206

    1 Names of Reporting Persons

    Saba Capital Management, L.P.
    2 Check the appropriate box if a member of a Group (see instructions)

    (a)  [ ]
    (b)  [ ]
    3 Sec Use Only

     
    4 Citizenship or Place of Organization

    Delaware
    Number of
    Shares
    Beneficially
    Owned by Each
    Reporting Person
    With:
    5 Sole Voting Power

    -0-
    6 Shared Voting Power

    -0-
    7 Sole Dispositive Power

    -0-
    8 Shared Dispositive Power

    -0-
    9 Aggregate Amount Beneficially Owned by Each Reporting Person

    -0-
    10 Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    [ ]
    11 Percent of class represented by amount in row (9)

    0%
    12 Type of Reporting Person (See Instructions)

    PN; IA
           

    The percentages used herein are calculated based upon 10,903,700 shares of common stock outstanding as of November 11, 2022, as disclosed in the company's 10-Q filed November 14, 2022

    Page 2 of 7


    SCHEDULE 13G/A

    CUSIP No.           31772T206

    1 Names of Reporting Persons

    Boaz R. Weinstein
    2 Check the appropriate box if a member of a Group (see instructions)

    (a)  [ ]
    (b)  [ ]
    3 Sec Use Only

     
    4 Citizenship or Place of Organization

    United States
    Number of
    Shares
    Beneficially
    Owned by Each
    Reporting Person
    With:
    5 Sole Voting Power

    -0-
    6 Shared Voting Power

    -0-
    7 Sole Dispositive Power

    -0-
    8 Shared Dispositive Power

    -0-
    9 Aggregate Amount Beneficially Owned by Each Reporting Person

    -0-
    10 Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    [ ]
    11 Percent of class represented by amount in row (9)

    0%
    12 Type of Reporting Person (See Instructions)

    IN
           

    The percentages used herein are calculated based upon 10,903,700 shares of common stock outstanding as of November 11, 2022, as disclosed in the company's 10-Q filed November 14, 2022.

    Page 3 of 7



    CUSIP No.           31772T206

    1 Names of Reporting Persons

    Saba Capital Management GP, LLC
    2 Check the appropriate box if a member of a Group (see instructions)

    (a)  [ ]
    (b)  [ ]
    3 Sec Use Only

     
    4 Citizenship or Place of Organization

    Delaware
    Number of
    Shares
    Beneficially
    Owned by Each
    Reporting Person
    With:
    5 Sole Voting Power

    -0-
    6 Shared Voting Power

    -0-
    7 Sole Dispositive Power

    -0-
    8 Shared Dispositive Power

    -0-
    9 Aggregate Amount Beneficially Owned by Each Reporting Person

    -0-
    10 Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    [ ]
    11 Percent of class represented by amount in row (9)

    0%
    12 Type of Reporting Person (See Instructions)

    OO
           

    The percentages used herein are calculated based upon 10,903,700 shares of common stock outstanding as of November 11, 2022, as disclosed in the company's 10-Q filed November 14, 2022

    Page 4 of 7


    Item 1.

    (a) Name of Issuer: Financial Strategies Acquisition Corp

    (b) Address of Issuer's Principal Executive Offices: 2626 Cole Avenue, Suite 300, Dallas, TX 75204

    Item 2.

    (a) Name of Person Filing: Saba Capital Management, L.P., a Delaware limited partnership ("Saba Capital"), Saba Capital Management GP, LLC, a Delaware limited liability company ("Saba GP"), and Mr. Boaz R. Weinstein (together, the "Reporting Persons").  The Reporting Persons have entered into a Joint Filing Agreement, dated December 20, 2021, pursuant to which the Reporting Persons have agreed to file this statement and any subsequent amendments hereto jointly in accordance with the provisions of Rule 13d-1(k)(1) under the Act.  Any disclosures herein with respect to persons other than the Reporting Persons are made on information and belief after making inquiry to the appropriate party.  The filing of this statement should not be construed as an admission that any of the forgoing persons or the Reporting Persons is, for the purposes of Section 13 of the Act, the beneficial owner of the Common Stock reported herein.

    (b) Address of Principal Business Office or, if None, Residence:  The address of the business office of each of the Reporting Persons is 405 Lexington Avenue, 58th Floor, New York, New York 10174.

    (c) Citizenship: Saba Capital is organized as a limited partnership under the laws of the State of Delaware. Saba GP is organized as a limited liability company under the laws of the State of Delaware. Mr. Weinstein is a citizen of the United States.

    (d) Title and Class of Securities: Common stock, $0.0001 Par Value (the "Common Stock").

    (e) CUSIP No.: 31772T206

    Item 3.  If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

    (a) [_] Broker or dealer registered under Section 15 of the Act;

    (b) [_] Bank as defined in Section 3(a)(6) of the Act;

    (c) [_] Insurance company as defined in Section 3(a)(19) of the Act;

    (d) [_] Investment company registered under Section 8 of the Investment Company Act of 1940;

    (e) [_] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);

    (f) [_] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);

    (g) [_] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);

    (h) [_] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

    Page 5 of 7


    (i) [_] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940;

    (j) [_] A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J);

    (k) [_] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____

    Item 4. Ownership

    (a) Amount Beneficially Owned:    The information required by Items 4(a) - (c) is set forth in Rows (5) - (11) of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person.

    Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [X]

    Item 6. Ownership of more than Five Percent on Behalf of Another Person.  N/A

    Item 7. Identification and classification of the subsidiary which acquired the security being reported on by the parent holding company or control person. N/A

    Item 8. Identification and classification of members of the group. N/A

    Item 9. Notice of Dissolution of Group.  N/A

    Item 10. Certifications.

    By signing below each Reporting Person certifies that, to the best of his or its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

    Page 6 of 7


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dated:  February 14, 2023

    /s/ Signature  Michael D'Angelo

    Name: Michael D'Angelo

    Title: Chief Compliance Officer

    Boaz R. Weinstein

    By: Michael D'Angelo

    Title: Attorney-in-fact***

    *** Pursuant to a Power of Attorney dated as of November 16, 2015

    Page 7 of 7


    Get the next $FXCO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $FXCO

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $FXCO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Schinzing Alexander V converted options into 1,851,250 shares

    4 - Financial Strategies Acquisition Corp. (0001817565) (Issuer)

    2/6/23 6:06:23 AM ET
    $FXCO
    Blank Checks
    Finance

    SEC Form 3 filed by new insider Vainionpaa Timo

    3 - Financial Strategies Acquisition Corp. (0001817565) (Issuer)

    6/21/22 5:26:50 PM ET
    $FXCO
    Blank Checks
    Finance

    SEC Form 3 filed by new insider Minkowitz Daniel

    3 - Financial Strategies Acquisition Corp. (0001817565) (Issuer)

    6/21/22 5:25:59 PM ET
    $FXCO
    Blank Checks
    Finance

    $FXCO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $FXCO
    SEC Filings

    View All

    Financial Strategies Acquisition Corp. Announces Merger with Austin Biosciences Corp, A Texas Biotechnology Platform Company

    DALLAS and AUSTIN, Texas, Feb. 13, 2023 /PRNewswire/ -- Financial Strategies Acquisition Corp. (NASDAQ:FXCO) ("FXCO")(the "Company")., a Special Purpose Acquisition Company led by CEO Alexander V. Schinzing, today announced the execution of a definitive business combination agreement with Austin Biosciences Corp. ("Austin Biosciences"). Upon closing of the transaction, Austin Biosciences will become a wholly-owned subsidiary of the Company. Mr. Schinzing will serve as Chairman and Mr. Burgi-Krishnamurthy will serve as Chief Executive Officer of Austin Biosciences. The Company'

    2/13/23 4:29:00 PM ET
    $FXCO
    Blank Checks
    Finance

    Financial Strategies Acquisition Corp. Announces Extension of Termination Date and Additional Contribution to Trust Account to Extend Termination Date

    DALLAS, Feb. 9, 2023 /PRNewswire/ -- Financial Strategies Acquisition Corp. (NASDAQ:FXCO, the ", Company", ))), a special purpose acquisition company, announced today that its Board of Directors (the "Board") has approved an extension of the period of time available to the Company to consummate an initial business combination by one month from February 14, 2023 to March 14, 2023 (the "Termination Date"), as permitted under the Company's amended and restated certificate of incorporation, as amended. The purpose of the extension is to provide additional time for the Company to complete an initial business combination.

    2/9/23 5:33:00 PM ET
    $FXCO
    Blank Checks
    Finance

    Financial Strategies Acquisition Corp. Announces Extension of Termination Date and Additional Contribution to Trust Account to Extend Termination Date

    DALLAS, Jan. 11, 2023 /PRNewswire/ -- Financial Strategies Acquisition Corp. (NASDAQ:FXCO, the ", Company", ))), a special purpose acquisition company, announced today that its Board of Directors (the "Board") has approved an extension of the period of time available to the Company to consummate an initial business combination by one month from January 14, 2023 to February 14, 2023 (the "Termination Date"), as permitted under the Company's amended and restated certificate of incorporation, as amended. The purpose of the extension is to provide additional time for the Company to complete an initial business combination. In connection with the extension, Temmelig Investor LLC, an affiliate of

    1/11/23 4:30:00 PM ET
    $FXCO
    Blank Checks
    Finance

    SEC Form 25-NSE filed by Financial Strategies Acquisition Corp.

    25-NSE - Financial Strategies Acquisition Corp. (0001817565) (Subject)

    11/20/23 8:45:34 AM ET
    $FXCO
    Blank Checks
    Finance

    Financial Strategies Acquisition Corp. filed SEC Form 8-K: Changes in Registrant’s Certifying Accountant, Financial Statements and Exhibits

    8-K - Financial Strategies Acquisition Corp. (0001817565) (Filer)

    8/11/23 4:00:25 PM ET
    $FXCO
    Blank Checks
    Finance

    Financial Strategies Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - Financial Strategies Acquisition Corp. (0001817565) (Filer)

    6/15/23 4:02:24 PM ET
    $FXCO
    Blank Checks
    Finance

    $FXCO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Financial Strategies Acquisition Corp. (Amendment)

    SC 13G/A - Financial Strategies Acquisition Corp. (0001817565) (Subject)

    2/5/24 3:11:44 PM ET
    $FXCO
    Blank Checks
    Finance

    SEC Form SC 13G filed by Financial Strategies Acquisition Corp.

    SC 13G - Financial Strategies Acquisition Corp. (0001817565) (Subject)

    2/21/23 12:30:49 PM ET
    $FXCO
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by Financial Strategies Acquisition Corp. (Amendment)

    SC 13G/A - Financial Strategies Acquisition Corp. (0001817565) (Subject)

    2/14/23 10:27:21 AM ET
    $FXCO
    Blank Checks
    Finance